IOL Chemicals and Pharmaceuticals Limited — Updates, 10-08-2026: Press Release
10-08-2026 | 05:52 pm
10-08-2026 | 05:52 pm
IOL Chemicals reports record Q1 FY27 results: Revenue up 37.1% to ₹756.3 Cr, PAT surged 89.9% to ₹64.5 Cr. Performance driven by improved capacity utilization, product mix. Clopidogrel API received NMPA approval in China, expanding market access.
No comments yet. Be the first to comment!
All announcements from IOL Chemicals and Pharmaceuticals Limited
